FBB
IDXX icon

Fulton Breakefield Broenniman’s Idexx Laboratories IDXX Stock Holding History

Fulton Breakefield Broenniman’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,160
Closed -$315K – 189
2019
Q3 		$315K Buy
+1,160
New +$323K 0.04% 137

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fulton Breakefield Broenniman's IDXX Position: Q4 2019 in Review

Fulton Breakefield Broenniman sold out of Idexx Laboratories (IDXX) in Q4 2019, closing a stake of 1,160 shares — an estimated $315K sold.

Fulton Breakefield Broenniman first reported a position in IDXX in Q3 2019 and held it in 1 quarter. The position peaked at $315K in Q3 2019. 761 funds tracked by Wall St. Rank hold IDXX as of Q4 2019.

  • Fulton Breakefield Broenniman reported no remaining Idexx Laboratories position as of Q4 2019 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 1,160 Idexx Laboratories shares in Q4 2019, an estimated $315K.
  • Fulton Breakefield Broenniman first reported a position in Idexx Laboratories in Q3 2019 and held it in 1 quarter.
  • Fulton Breakefield Broenniman's Idexx Laboratories position peaked at $315K in Q3 2019.
  • 761 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2019.

Based on Fulton Breakefield Broenniman's 13F filing for Q4 2019, filed 14 Jan 2020.